Key result
Donor-derived and early cholesterol embolization in renal allografts were associated with graft loss.
Why the study?
What are the clinicopathologic features and prognostic significance of cholesterol embolization in renal allografts?
Observational (n=37)
Yes
What are the clinicopathologic features and prognostic significance of cholesterol embolization in renal allografts?
Answers are grounded in this paper and cite their sources.
In renal allografts, cholesterol embolization is most often correlated with atherosclerosis and graft failure is significantly associated with donor-derived and early CE.
Cholesterol embolization (CE) in renal allografts is a rare occurrence, the natural history and prognostic significance of which is poorly characterized. We studied the clinicopathologic features and outcome of the largest known series of CE in renal allografts and combined our cases with those in the literature. We identified renal allograft biopsies with CE from 1997 to September 2004 at University of Pittsburgh Medical Center (UPMC). All pathology material related to such biopsies were examined and correlated with clinical information to determine the most probable CE source. Among 5435 RAB, 19 from 12 cadaveric transplant recipients comprising 7 males and 5 females (median age=63 y) had CE. Donors consisted of 9 males and 2 females (median age=47 y). One donor's age and sex was unknown. The most probable CE source was recipient in 9 cases and donor in 3 cases. Five had acute renal failure without acute cellular rejection and 2 had CE-specific failed allografts. Of 19 RAB, the most frequent coexisting diagnosis was chronic allograft nephropathy (63%). The median follow-up time was 661 days. Combining UPMC and non-UPMC cases (n=37) revealed a statistically significant loss of grafts with donor-derived (P value=0.00459) and early CE (P value=0.00938). In renal allografts, CE most often correlated with recipient and donor atherosclerosis. It may present with acute renal failure, but usually not acute graft loss. Graft failure is significantly associated with donor-derived and early CE. Although its prognosis may be poor in the setting of primary nonfunction, prolonged graft survival may be seen.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2007) conducted an observational in Cholesterol embolization in renal allografts (n=37). Donor-derived and early cholesterol embolization was evaluated on Graft loss (p=0.00459 (donor-derived), 0.00938 (early CE)). Donor-derived and early cholesterol embolization in renal allografts were associated with graft loss.
Synapse has enriched 10 related papers. Consider them for comparative context: